How much did PaxMedica raise?

PaxMedica raised $3.2 Million in a Seed round on February 3, 2023.

Who are the decision-makers at PaxMedica?

Fundz holds 1 contact at PaxMedica. Names and contact details are shown to Fundz members.

Paxmedica, Inc. Secures $3.2 Million Growth Capital From Lind Partners

PRIVATEFeb 03, 2023

Amount Raised

$3.2 Million

Round Type

Seed

TarrytownBiotechnology

Description

via NewMediaWire

Quick answer

PaxMedica raised $3.2 Million in a Seed round, dated February 3, 2023. PaxMedica is based in Tarrytown, New York, United States.

How much did PaxMedica raise?: PaxMedica raised $3.2 Million in a Seed round on February 3, 2023.
What does PaxMedica do?: PaxMedica is a clinical stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, ranging from..
Where is PaxMedica based and how big is it?: PaxMedica is based in Tarrytown, New York, United States.
Who are the decision-makers at PaxMedica?: Fundz holds 1 contact at PaxMedica. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as PaxMedica that raised within 45 days of this round, from Fundz verified event records.

CalciMedica raised $10M on March 20, 2023.
CalciMedica raised $9.1M on March 20, 2023.
AERA Health raised $4.3M (Seed) on March 20, 2023.
GT Medical Technologies raised $37M on March 20, 2023.
Microbix Biosystems Inc. raised an undisclosed amount (Funding Round) on March 20, 2023.
Clarapath raised $11M on March 20, 2023.

Who to call at PaxMedica, and when

A new round usually means PaxMedica is about to hire and buy. The teams that reach out first get the meeting.

An alert the day PaxMedica raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at PaxMedica, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PaxMedica. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PaxMedica

Location

303 SOUTH BROADWAY, SUITE 125

Tarrytown, New York, United States

About

PaxMedica is a clinical stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including Autism Spectrum Disorder (“ASD”), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (“ME/CFS”), a debilitating physical and cognitive disorder believed to be viral in origin and now with rising incidence globally due to the long term effects of SARS-CoV-2 (“COVID-19”). One of PaxMedica’s primary points of focus is the development and testing of its lead program, PAX-101, an intravenous formulation of suramin, in the treatment of ASD and the advancement of the clinical understanding of using that agent against other disorders such as ME/CFS and Long COVID-19 Syndrome, a clinical diagnosis in individuals who have been previously infected with COVID-19.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PaxMedica raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contacts8 people are listed at PaxMedica. We don't have their email yet.See plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for PaxMedica's next move

See what Strategic adds

PaxMedica raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.